| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |